Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Blood-Based Biomarkers Could Detect Alzheimer's as Early as Middle Age

By LabMedica International staff writers
Posted on 15 Jul 2025

As the global population ages, Alzheimer's disease and other dementing diseases are becoming more prevalent. More...

The disease processes leading to Alzheimer's symptoms can begin years or even decades before cognitive decline becomes apparent. Detecting the disease at its early stages is challenging, and the current methods for identifying Alzheimer's, such as imaging studies or cerebrospinal fluid sampling, are invasive and costly. Furthermore, the identification of biomarkers associated with Alzheimer’s is not well-established in younger populations. Now, a Finnish population study has shown that signs related to Alzheimer’s disease may already be found in the brain in middle age. In the future, blood-based biomarkers associated with Alzheimer's could allow earlier detection of the disease. This would allow preventive treatment to be targeted at the right individuals while the disease is still at the mild stage.

The study conducted at the University of Turku in Finland (Turku, Finland investigated blood-based biomarkers as a method for detecting Alzheimer’s risk. The study involved middle-aged participants (ages 41–56) and their parents (ages 59–90), totaling 2,051 individuals. The researchers measured the levels of biomarkers in the blood to understand how these levels may be associated with Alzheimer’s, particularly in middle-aged individuals. The study found that high levels of certain blood-based biomarkers associated with Alzheimer’s were already present in middle-aged individuals, with concentrations increasing with age. A key finding was the association between high biomarker levels in parents, especially mothers, and higher biomarker levels in their middle-aged offspring.

These findings, published in Lancet Healthy Longevity, demonstrates that blood-based biomarkers could be a promising tool for detecting Alzheimer's at earlier stages. Although the blood sample method is not yet definitive for diagnosing Alzheimer's, the study shows potential for identifying individuals at risk using this non-invasive approach. It was also found that kidney disease may be linked to higher biomarker levels in middle age, while the APOE ε4 gene, which increases Alzheimer's risk, was associated with higher biomarker levels in older age but not in middle age. The findings suggest that blood-based biomarkers could become a cost-effective and less invasive diagnostic method in the future, but more research is needed to standardize reference values and account for confounding factors.

“Until now, brain biomarkers associated with Alzheimer's disease have mainly been studied in older individuals. Our study provides new insights into biomarker levels and associated factors starting from middle age," said Marja Heiskanen, Senior Researcher at the University of Turku.


New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Pipette
Accumax Smart Series
New
Specimen Radiography System
TrueView 200 Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.